Boston Scientific Cuts Forecast on Product Slowdown and Competition
Boston Scientific Corporation (NYSE: BSX ) stock is trading lower after the company cut its fiscal 2026 outlook, citing pressures on the Watchman and EP markets. Q2 Beats Estimates The medical technology giant reported revenues of $5.442 billion on Wednesday, better than the consensus estimate of $5.361 billion, beating the management guidance of $5.34 billion-$5.44 billion. The medical devices maker reported adjusted earnings of 86 cents, beating the consensus of 83 cents and the management guidance of 82-84 cents. “Our team delivered a solid quarter while continuing to navigate a dynamic environment,” said Mike Mahoney, chairman and CEO of Boston Scientific. “We are focused on disciplined execution and prioritizing investments in our highest-impact opportunities…” Read Also: Boston Scientific Advances Coronary Calcium Treatment With Positive Trial Resul...
Boston Scientific Corporation (NYSE: BSX ) stock is trading lower after the company cut its fiscal 2026 outlook, citing pressures on the Watchman and EP markets. 44 billion. The medical devices maker reported adjusted earnings of 86 cents, beating the consensus of 83 cents and the management guidance of 82-84 cents. “Our team delivered a solid quarter while continuing to navigate a dynamic environment,” said Mike Mahoney, chairman and CEO of Boston Scientific.
36. 562 billion. S. S.
market. The company said, “While we are sharpening our forecasting processes and taking action to address controllable headwinds, our underlying assumptions are that these dynamics continue in 2027, resulting in revenue growth below our WAMGR and limited adjusted EPS growth. 358 billion. The medtech giant expects adjusted earnings of 80-82 cents versus the consensus of 83 cents.
Restructuring Plan Targets Long-Term Cost Savings Earlier this week, Boston Scientific initiated a restructuring plan. The company, in an SEC filing, said the plan will generate $700 million to $800 million in total pre-tax charges, including $600 million to $700 million in future cash outlays. Once fully implemented, the company expects the restructuring to reduce gross annual pre-tax expenses by about $500 million, with a significant portion of the savings earmarked for strategic growth investments. 22 at the time of publication Wednesday, according to Pro data.
Image via Shutterstock Read Also: Apple's Incoming CEO John Ternus Signals More Apple TV Growth as Tim Cook Teases More Formula 1-Style Bets: 'We'll Do Things That…'